Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hypoacusis
ADR ID BADD_A04745
ADR Hierarchy
04      Ear and labyrinth disorders
04.02      Hearing disorders
04.02.01      Hearing losses
04.02.01.006      Hypoacusis
Description A general term for the complete or partial loss of the ability to hear from one or both ears. [MeSH]
MedDRA Code 10048865
MeSH ID D034381
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Auditory hypoacuity | Hearing decreased | Hearing impaired | Hearing reduced | Hypoacuity auditory | Muffled hearing in both ears | Worsening of auditory acuity | Hearing impairment aggravated | Hypoacusis | Hypoacusis unilateral | Hard of hearing | Partial hearing loss | Hearing Loss | Loss, Hearing | Hypoacuses | Hearing Impairment
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02006Selexipag0.000642%
BADD_D02010Sertraline0.000149%
BADD_D02018Sildenafil0.002888%
BADD_D02028Sirolimus0.000295%
BADD_D02029Sitagliptin0.000159%
BADD_D02071Streptomycin--
BADD_D02093Sulfasalazine--
BADD_D02097Sulindac--
BADD_D02098Sumatriptan--
BADD_D02099Sumatriptan succinate--
BADD_D02100Sunitinib--
BADD_D02105Tacrolimus--
BADD_D02106Tadalafil0.001815%
BADD_D02107Tafamidis0.009206%
BADD_D02118Tasimelteon0.000131%
BADD_D02141Teichomycin--
BADD_D02147Telmisartan0.000260%
BADD_D02150Temozolomide--
BADD_D02160Terbinafine0.000402%
BADD_D02161Terbinafine hydrochloride--
BADD_D02192Thalidomide0.002266%
BADD_D02203Thiotepa--
BADD_D02217Tigecycline0.000049%
BADD_D02232Tobramycin--
BADD_D02236Tofacitinib0.033611%
BADD_D02244Tolterodine0.001379%
BADD_D02247Topiramate0.000226%
BADD_D02265Travoprost0.004243%
BADD_D02266Trazodone--
BADD_D02270Tretinoin--
The 9th Page    First    Pre   9 10    Next   Last    Total 10 Pages